Clinical Trial Update: Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating sunitinib in combination with cisplatin and 5-fluorouracil for advanced gastric cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Stomach Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2011-01-05